Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5283993
Chembl Id: CHEMBL5283993
Max Phase: Preclinical
Molecular Formula: C34H49N7O5S
Molecular Weight: 667.88
Associated Items:
ID: ALA5283993
Chembl Id: CHEMBL5283993
Max Phase: Preclinical
Molecular Formula: C34H49N7O5S
Molecular Weight: 667.88
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CN3CCN(C)CC3)nc3[nH]cnc23)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C34H49N7O5S/c1-7-32(4)16-23(33(5)20(2)8-10-34(21(3)28(32)45)11-9-22(42)27(33)34)46-25(44)18-47-30-26-29(36-19-35-26)38-31(39-30)37-24(43)17-41-14-12-40(6)13-15-41/h7,19-21,23,27-28,45H,1,8-18H2,2-6H3,(H2,35,36,37,38,39,43)/t20-,21+,23-,27?,28+,32-,33+,34+/m1/s1
Standard InChI Key: FDFCAEOLTKTFJJ-SIZKMEIFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 667.88 | Molecular Weight (Monoisotopic): 667.3516 | AlogP: 3.54 | #Rotatable Bonds: 8 |
Polar Surface Area: 153.64 | Molecular Species: BASE | HBA: 11 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 6.88 | CX Basic pKa: 9.93 | CX LogP: 3.39 | CX LogD: 3.17 |
Aromatic Rings: 2 | Heavy Atoms: 47 | QED Weighted: 0.16 | Np Likeness Score: 0.44 |
1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y.. (2023) Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives., 14 (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004] |
Source(1):